United States, EU, Japan, China, India and Southeast Asia Bispecific Antibody Therapeutic Market Size, Status and Forecast 2021

December 2016 | 92 pages | ID: UEA49C54902EN
QYResearch

Abstracts

Notes:

Production, means the output of Bispecific Antibody Therapeutic

Revenue, means the sales value of Bispecific Antibody Therapeutic

This report studies the global Bispecific Antibody Therapeutic market, analyzes and researches the Bispecific Antibody Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Amgen
• Merrimack Pharmaceuticals
• Affimed
• Merus
• OncoMed Pharmaceuticals

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Application, Bispecific Antibody Therapeutic can be split into

• Application 1
• Application 2
• Application 3

Contents

United States, EU, Japan, China, India and Southeast Asia Bispecific Antibody Therapeutic Market Size, Status and Forecast 2021

1 INDUSTRY OVERVIEW OF BISPECIFIC ANTIBODY THERAPEUTIC

1.1 Bispecific Antibody Therapeutic Market Overview
  1.1.1 Bispecific Antibody Therapeutic Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Bispecific Antibody Therapeutic Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Bispecific Antibody Therapeutic Market by End Users/Application
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application

2 GLOBAL BISPECIFIC ANTIBODY THERAPEUTIC COMPETITION ANALYSIS BY PLAYERS

2.1 Bispecific Antibody Therapeutic Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Amgen
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Bispecific Antibody Therapeutic Revenue (Value) (2011-2016)
  3.1.5 Recent Developments
3.2 Merrimack Pharmaceuticals
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Bispecific Antibody Therapeutic Revenue (Value) (2011-2016)
  3.2.5 Recent Developments
3.3 Affimed
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Bispecific Antibody Therapeutic Revenue (Value) (2011-2016)
  3.3.5 Recent Developments
3.4 Merus
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Bispecific Antibody Therapeutic Revenue (Value) (2011-2016)
  3.4.5 Recent Developments
3.5 OncoMed Pharmaceuticals
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Bispecific Antibody Therapeutic Revenue (Value) (2011-2016)
  3.5.5 Recent Developments

4 GLOBAL BISPECIFIC ANTIBODY THERAPEUTIC MARKET SIZE BY APPLICATION (2011-2016)

4.1 Global Bispecific Antibody Therapeutic Market Size by Application (2011-2016)
4.2 Potential Application of Bispecific Antibody Therapeutic in Future
4.3 Top Consumer/End Users of Bispecific Antibody Therapeutic

5 UNITED STATES BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Bispecific Antibody Therapeutic Market Size (2011-2016)
5.2 United States Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

6 EU BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Bispecific Antibody Therapeutic Market Size (2011-2016)
6.2 EU Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

7 JAPAN BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Bispecific Antibody Therapeutic Market Size (2011-2016)
7.2 Japan Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

8 CHINA BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

8.1 China Bispecific Antibody Therapeutic Market Size (2011-2016)
8.2 China Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

9 INDIA BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

9.1 India Bispecific Antibody Therapeutic Market Size (2011-2016)
9.2 India Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

10 SOUTHEAST ASIA BISPECIFIC ANTIBODY THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Bispecific Antibody Therapeutic Market Size (2011-2016)
10.2 Southeast Asia Bispecific Antibody Therapeutic Market Size and Market Share by Players (2015-2016)

11 MARKET FORECAST BY REGIONS AND APPLICATION (2016-2021)

11.1 Global Bispecific Antibody Therapeutic Market Size (Value) by Regions (2016-2021)
11.2 Global Bispecific Antibody Therapeutic Market Size (Value) by Application (2016-2021)
11.3 The Market Drivers in Future

12 BISPECIFIC ANTIBODY THERAPEUTIC MARKET DYNAMICS

12.1 Bispecific Antibody Therapeutic Market Opportunities
12.2 Bispecific Antibody Therapeutic Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Bispecific Antibody Therapeutic Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Bispecific Antibody Therapeutic Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Bispecific Antibody Therapeutic Product Scope
Figure Global Bispecific Antibody Therapeutic Market Size (2011-2016)
Table Global Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure Global Bispecific Antibody Therapeutic Market Share by Regions in 2015
Figure United States Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure EU Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure Japan Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure India Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure Southeast Asia Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Figure Global Bispecific Antibody Therapeutic Market Share by Application in 2015
Figure Bispecific Antibody Therapeutic Market Size and Growth Rate in Applications 1 (2011-2016)
Figure Bispecific Antibody Therapeutic Market Size and Growth Rate in Applications 2 (2011-2016)
Figure Bispecific Antibody Therapeutic Market Size and Growth Rate in Applications 3 (2011-2016)
Table Bispecific Antibody Therapeutic Market Size (Value) by Players (2015-2016)
Figure Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Table Amgen Basic Information List
Table Bispecific Antibody Therapeutic Business Revenue of Amgen (2011-2016)
Figure Amgen Bispecific Antibody Therapeutic Business Revenue Market Share in 2015
Table Merrimack Pharmaceuticals Basic Information List
Table Bispecific Antibody Therapeutic Business Revenue of Merrimack Pharmaceuticals (2011-2016)
Figure Merrimack Pharmaceuticals Bispecific Antibody Therapeutic Business Revenue Market Share in 2015
Table Affimed Basic Information List
Table Bispecific Antibody Therapeutic Business Revenue of Affimed (2011-2016)
Figure Affimed Bispecific Antibody Therapeutic Business Revenue Market Share in 2015
Table Merus Basic Information List
Table Bispecific Antibody Therapeutic Business Revenue of Merus (2011-2016)
Figure Merus Bispecific Antibody Therapeutic Business Revenue Market Share in 2015
Table OncoMed Pharmaceuticals Basic Information List
Table Bispecific Antibody Therapeutic Business Revenue of OncoMed Pharmaceuticals (2011-2016)
Figure OncoMed Pharmaceuticals Bispecific Antibody Therapeutic Business Revenue Market Share in 2015
Table Global Bispecific Antibody Therapeutic Market Size by Application (2011-2016)
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2011
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2012
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2013
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2014
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2015
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2016
Table Top Consumer/End Users of Bispecific Antibody Therapeutic
Figure United States Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table United States Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure United States Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure United States Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure EU Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table EU Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure EU Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure EU Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure Japan Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table Japan Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure Japan Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure Japan Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table China Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure China Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure China Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure India Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table India Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure India Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure India Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure Southeast Asia Bispecific Antibody Therapeutic Market Size and Growth Rate by Regions (2011-2016)
Table Southeast Asia Bispecific Antibody Therapeutic Market Size by Players (2011-2016)
Figure Southeast Asia Bispecific Antibody Therapeutic Market Size Share by Players in 2015
Figure Southeast Asia Bispecific Antibody Therapeutic Market Size Share by Players in 2016
Figure Global Bispecific Antibody Therapeutic Market Size (Value) by Regions (2016-2021)
Table Global Bispecific Antibody Therapeutic Market Size by Regions (2016-2021)
Figure Global Bispecific Antibody Therapeutic Market Size Share by Regions in 2017
Figure Global Bispecific Antibody Therapeutic Market Size Share by Regions in 2021
Table Global Bispecific Antibody Therapeutic Market Size by Application (2016-2021)
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2017
Figure Global Bispecific Antibody Therapeutic Market Size by Application in 2021